increasing from $6.24 billion to $11.83 billion over the specified period. Notably, the report projects a compound annual growth rate of 14.2% for the rapid testing products segment due to its advantages such as accuracy in results and in less time and advent of technologically advanced devices. For American Screening LLC, providing a rich choice of rapid drug tests is a way to ensure optimal outcomes for all parties concerned, be it in emergency medical settings, corporate environments, or public places. Its products empower healthcare professionals, law enforcement officers, employers, and family members to make the right decisions and act quickly, thus preventing or rectifying situations with potentially fatal consequences.
American Screening LLC started in a small room in Shreveport, Louisiana as a family business on a mission to provide quality drug and alcohol testing products. Since its launch in 2004, the company has expanded steadily to become a top vendor of diagnostic tests and essential medical supplies to the United States, South America, Asia, Africa, Europe, and Australia. Much of its success is attributable to the founder, Ron Kilgarlin, who drew on his extensive expertise in business management, medical devices, product development, distribution, and marketing. Among the many things American Screening LLC takes pride in are its multiple certifications, including the highly coveted one issued under MDSAP (Medical Device Single Audit Program), which designates the company as compliant with the requirements for quality management systems in multiple jurisdictions.
American Screening, LLC Now Offers COVID-19 Antibody Rapid Serology Tests: https://www.biospace.com/article/releases/american-screening-llc-now-offers-covid-19-antibody-rapid-serology-tests/
American Screening LLC Founder, Ron Kilgarlin, on Improved Efficiency in Decision-Making with Rapid Drug Tests: https://apnews.com/article/coronavirus-pandemic-business-technology-health-4984166f0d2a716baa5137741175445b